In 2014, MAPS spun out a separate division to immediate investigation and prepare for an eventual FDA software, which it submitted at the end of past 12 months. In early 2024, that offshoot was renamed Lykos Therapeutics.Congratulations should you’ve read through this much and you believe you might be hooked on copyright crystal or other party me